Advertisements
Search

Disruptive Enterprises Closes its First External Funding Round

DURHAM, N.C. /PRNewswire/ — Disruptive Enterprises, LLC announced today that One Better Ventures (1BV) has become its first outside investor. One Better Ventures sought out Disruptive Enterprises due to its strong mission-driven culture and disruptive consumer products businesses advancing health and wellness. One Better Ventures nurtures and develops consumer brands with mission-driven companies that have breakthrough, innovative, and sustainable business models. Disruptive…

Advertisements
Read More

Express Scripts Endorses “Know the Lowest Price Act of 2018” and “Patient Right to Know Drug Prices Act

ST. LOUIS, March 16, 2018 /PRNewswire/ — Express Scripts (NASDAQ:ESRX) today released this statement in support of S. 2553, the “Know the Lowest Price Act of 2018,” introduced by U.S. Senators Stabenow, Collins, Wyden, Cassidy, McCaskill and Barrasso, and S. 2554, the “Patient Right to Know Drug Prices Act,” introduced by U.S. Senators Collins, McCaskill, Barrasso, Stabenow and Cassidy. Express…

Read More

Puration Announces EVERx CBD Infused Sports Water Instagram Campaign

DALLAS, /PRNewswire/ — Puration, Inc. (USOTC: PURA), the producer of EVERx CBD Infused Sports Water, today announced an Instagram campaign to feature all the pics of celebrity athletes and fans holding EVERx CBD Infused Sports Water and wearing EVERx gear at the recent Arnold Sports Festival in Columbus, Ohio.  Look for new pics to be posted everyday on Instagram @drinkeverx over the…

Read More

FDA approves new HIV treatment for patients who have limited treatment options

SILVER SPRING Md. /PRNewswire-USNewswire/ — Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV). Trogarzo is administered intravenously…

Read More

FDA warns of fraudulent and unapproved flu products

SILVER SPRING, Md. /PRNewswire-USNewswire/ — As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency is reminding consumers to be wary of unapproved products claiming to prevent, treat or cure influenza, or flu. This year’s severe flu season raises new concerns about the potential for consumers to be lured into buying unproven flu…

Read More
1 10 11 12 13 14 18